Cargando…
D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment
The effect of immunotherapy is limited by oncometabolite D-2-hydroxyglutarate (D2HG). D2HGDH is an inducible enzyme that converts D2HG into the endogenous metabolite 2-oxoglutarate. We aimed to evaluate the impairment of CD8 T lymphocyte function in the high-D2HG environment and to explore the pheno...
Autores principales: | Yang, Quanjun, Hao, Juan, Chi, Mengyi, Wang, Yaxian, Li, Jie, Huang, Jinlu, Zhang, Jianping, Zhang, Mengqi, Lu, Jin, Zhou, Shumin, Yuan, Ting, Shen, Zan, Zheng, Shuier, Guo, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899596/ https://www.ncbi.nlm.nih.gov/pubmed/35007759 http://dx.doi.org/10.1016/j.ymthe.2022.01.007 |
Ejemplares similares
-
Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
por: Krell, Daniel, et al.
Publicado: (2011) -
Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
por: Zhu, Xinting, et al.
Publicado: (2023) -
Structure, substrate specificity, and catalytic mechanism of human D-2-HGDH and insights into pathogenicity of disease-associated mutations
por: Yang, Jun, et al.
Publicado: (2021) -
D‐2‐hydroxyglutaric aciduria Type I: Functional analysis of D2HGDH missense variants
por: Pop, Ana, et al.
Publicado: (2019) -
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2
por: Lin, An-Ping, et al.
Publicado: (2015)